Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
6
×
pfizer
6
×
national blog main
biotech
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
amgen
breast cancer
gene therapy
immunotherapy
national
san francisco blog main
san francisco top stories
spark therapeutics
abbvie
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
american cancer society
amicus therapeutics
anylam pharmaceuticals
articles
artificial intelligence
arvinas
avelumab
batten disease
bayer
big pharma
biogen
biomarin
biontech
biovex
boehringer ingelheim
What
pfizer
drug
approved
bio
ceo
company
past
patients
world’s
acquisitions
ago
akcea
albert
alex
alnylam
amyloidosis
announced
argue
attr
available
based
battle
biggest
biontech
bourla
cancer
close
collaboration
combo
coming
companies
covid
crispr
data
dating
debilitating
decade
developed
discovery
disease
Language
unset
unknown
Current search:
pfizer���s
×
pfizer
×
" life sciences "
×
@techcrunch.com
2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea